BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14667220)

  • 1. Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors.
    Li X; Chu S; Feher VA; Khalili M; Nie Z; Margosiak S; Nikulin V; Levin J; Sprankle KG; Tedder ME; Almassy R; Appelt K; Yager KM
    J Med Chem; 2003 Dec; 46(26):5663-73. PubMed ID: 14667220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design, synthesis, and antimicrobial activity of purine derived SAH/MTA nucleosidase inhibitors.
    Tedder ME; Nie Z; Margosiak S; Chu S; Feher VA; Almassy R; Appelt K; Yager KM
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3165-8. PubMed ID: 15149667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics.
    Stiff C; Graber DR; Thorarensen A; Wakefield BD; Marotti KR; Melchior EP; Sweeney MT; Han F; Rohrer DC; Zurenko GE; Romero DL
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6293-7. PubMed ID: 18951783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3,3a,4,5,6,7-hexahydro-2H-indazoles.
    Minu M; Thangadurai A; Wakode SR; Agrawal SS; Narasimhan B
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2960-4. PubMed ID: 19410452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-driven HtL: design and synthesis of novel aminoindazole inhibitors of c-Jun N-terminal kinase activity.
    Stocks MJ; Barber S; Ford R; Leroux F; St-Gallay S; Teague S; Xue Y
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3459-62. PubMed ID: 15950471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes.
    Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.
    McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3.
    Swahn BM; Huerta F; Kallin E; Malmström J; Weigelt T; Viklund J; Womack P; Xue Y; Ohberg L
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5095-9. PubMed ID: 16140012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, antimicrobial activity and structure-activity relationships of new aryldisulfonamides.
    Alyar S; Karacan N
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):986-92. PubMed ID: 19548771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural comparison of MTA phosphorylase and MTA/AdoHcy nucleosidase explains substrate preferences and identifies regions exploitable for inhibitor design.
    Lee JE; Settembre EC; Cornell KA; Riscoe MK; Sufrin JR; Ealick SE; Howell PL
    Biochemistry; 2004 May; 43(18):5159-69. PubMed ID: 15122881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
    Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
    J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities.
    Umemura E; Wakiyama Y; Kumura K; Ueda K; Masaki S; Watanabe T; Yamamoto M; Hirai Y; Fushimi H; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2013 Mar; 66(3):195-8. PubMed ID: 23232934
    [No Abstract]   [Full Text] [Related]  

  • 14. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
    Procopiou PA; Ford AJ; Graves RH; Hall DA; Hodgson ST; Lacroix YM; Needham D; Slack RJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2730-3. PubMed ID: 22437117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
    Wiener JJ; Gomez L; Venkatesan H; Santillán A; Allison BD; Schwarz KL; Shinde S; Tang L; Hack MD; Morrow BJ; Motley ST; Goldschmidt RM; Shaw KJ; Jones TK; Grice CA
    Bioorg Med Chem Lett; 2007 May; 17(10):2718-22. PubMed ID: 17382544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors.
    Bouissane L; El Kazzouli S; Léonce S; Pfeiffer B; Rakib EM; Khouili M; Guillaumet G
    Bioorg Med Chem; 2006 Feb; 14(4):1078-88. PubMed ID: 16274996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
    Wyss PC; Gerber P; Hartman PG; Hubschwerlen C; Locher H; Marty HP; Stahl M
    J Med Chem; 2003 Jun; 46(12):2304-12. PubMed ID: 12773035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae.
    Yong H; Gu YG; Clark RF; Marron T; Ma Z; Soni N; Stone GG; Nilius AM; Marsh K; Djuric SW
    Bioorg Med Chem Lett; 2005 May; 15(10):2653-8. PubMed ID: 15863336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studies.
    Gerpe A; Aguirre G; Boiani L; Cerecetto H; González M; Olea-Azar C; Rigol C; Maya JD; Morello A; Piro OE; Arán VJ; Azqueta A; de Ceráin AL; Monge A; Rojas MA; Yaluff G
    Bioorg Med Chem; 2006 May; 14(10):3467-80. PubMed ID: 16483783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.
    Ali Na; Zakir S; Patel M; Farooqui M
    Eur J Med Chem; 2012 Apr; 50():39-43. PubMed ID: 22341789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.